UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

PSYCHOSOMATIC DYSSOMNIA IN PATIENTS WITH DIFFERENT FORMS OF DIFFUS*E ALOPECIA: VARIABILITY AND INTENSITY OF CLINICAL MANIFESTATIONS

Type of Article

In the Section

Abstract

The purpose of the work is to analyze the presence, variability and intensity of sleep disturbances in patients with diffuse alopecia, in order to create, in the future, differentiated and individualized approaches to the management of this category of patients.

153 women aged 25 to 45 with diffuse alopecia were examined. With the help of a structured interview according to the ICD-10 criteria and the use of a psychodiagnostic method, three groups were distinguished among patients: without signs of mental maladjustment (MM), numbering 45 people, with separate signs of maladjustment, numbering 73 people, and with the presence of adaptation disorders, respectively to the criteria of ICD-10, numbering 35 people. Within each of these groups, two subgroups were distinguished, taking into account the genesis of alopecia: metabolic (45 patients) or mixed (108 patients).

It was established that in the structure of psychosomatic clinical manifestations of the pathological trichological process in patients with diffuse alopecia, the entire variable spectrum of clinical dyssomnia symptoms is found — early, middle, late dyssomnias, nightmares and lack of rest after waking up — the prevalence and intensity of which are associated with the genesis of dermatological pathology (metabolic or mixed forms of alopecia).

Among patients with a mixed form of diffuse alopecia, psychosomatic dyssomnic manifestations have a significantly greater representation and severity than among patients with metabolic alopecia, which is confirmed by the presence of statistically significant differences.

An understandable tendency to increase the incidence of dyssomnic symptoms with the deterioration of the mental health of the subjects was recorded: from the absence and minimal presence and severity of individual manifestations in persons with signs of MM, with an increase in the variability and intensity of dyssomnic manifestations in patients of the risk group for the development of adaptation disorders, to the maximum presentation and severity of any sleep disorders in patients with adjustment disorder.

It was also established that the clinical content and severity of the entire spectrum of dyssomnic symptoms differ more significantly in patients with mixed alopecia (with a natural increase in the severity of all dyssomnic manifestations in parallel with the increase in the severity of MM) than in patients with its metabolic form, demonstrating more significant differences between indicators in persons of different groups according to the state of mental health within one form of alopecia.

The identified regularities should be taken into account when building a strategy of differentiated and individualized curation of patients with diffuse alopecia.

Pages

References

  1. Son iak nevid’iemna ckladova fizychnoho ta psykhichnoho zdorov’ia. NeiroNEWS. 2023. 9 (145):5—6 https://neuronews.com.ua/uploads/issues/2023/9(145)/nn23_9_5-6.pdf.
  2. The need to promote sleep health in public health agendas across the globe / Lim, Diane & Najafi, Arezu & Afifi, Lamia & Bassetti [et al.] // The Lancet Public Health. 2023. 8. e820-e826. DOI: https://doi.org/10.1016/S2468-2667(23)00182-2.
  3. Sleep Problems Associate With Multimorbidity: A Systematic Review and Meta-analysis / Zhou Y., Jin Y., Zhu Y. // Public Health Rev. 2023. 44:1605469. DOI: https://doi.org/10.3389/phrs.2023.1605469.
  4. Ohorenko V., Shornikov A. Porushennia snu ta iakist zhyttia zdobuvachiv medychnoi osvity pid chas voiennoho stanu [Sleep disturbance and quality of life in medical students during martial law.]. PMGP [internet]. 30, Berezen 2023; 8(1):e0801439. https://uk.e-medjournal.com/index.php/psp/article/view/439.
  5. Insomnia disorder: State of the science and challenges for the future / Riemann D., Benz F., Dressle R. J. [et al.] // Journal of Sleep Research. 2022;31(4):e13604. DOI: https://doi.org/10.1111/jsr.13604.
  6. Khyts A. R. Dity z atopichnym dermatytom ta porushenniam snu: efektyvnist zastosuvannia melatoninu [Children with atopic dermatitis and sleep disorders: efficacy of melatonin] Ukrainskyi Medychnyi Chasopys [Ukrainian Medical Journal]. 27 lypnia 2020. www.umj.com.ua/uk/novyna-184476-diti-z-atopichnim-dermatitom-ta-porushennyam-snu-efektivnist-zastosuvannya-melatoninu).